预防、诊断和治疗产后出血的成本效益:经济学评价的系统综述
该系统综述检索多个数据库,纳入56项产后出血预防、诊断或治疗干预的经济学评价,涵盖16种干预措施。氨甲环酸用于产后出血治疗以及综合产后出血 bundles 在多种环境下具有支持性成本效益证据。作者认为需要更多采用最佳实践原则的研究才能得出更强结论。
要点
- 氨甲环酸用于产后出血治疗和综合产后出血 bundles 在多项研究中显示具成本效益。
- 世界卫生组织推荐的额外宫缩剂、非充气抗休克衣或宫腔球囊填塞等干预缺乏稳健经济学评价。
- 纳入研究的环境、方法和结果差异很大,需更多采用最佳实践原则的研究。
核心结论
- 氨甲环酸作为产后出血治疗的一部分以及用于预防、诊断和治疗的综合性产后出血 bundles 在多种环境下具有支持性成本效益证据。
- 需要更多利用最佳实践原则的研究才能就哪些干预提供最佳价值得出更强结论。
- 世界卫生组织推荐的若干高优先级干预(如给予额外宫缩剂、非充气抗休克衣或宫腔球囊填塞用于产后出血管理)需要在高、中、低资源环境下开展稳健的经济学评价。
研究设计与样本
- 系统综述,前瞻性注册于 PROSPERO(CRD42023438424)。
- 检索 Medline、Embase、NHS EED、EconLit、CINAHL、Emcare、Web of Science 和 Global Index Medicus,检索时间为2023年6月22日至2024年7月11日,无日期或语言限制。
- 纳入任何产后干预用于预防、检测或管理产后出血的完整经济学评价。
- 研究筛选、数据提取和质量评估(使用 CHEC-E 工具)由至少2名评价者独立完成。
- 从3993条引文中共纳入56项研究:33项预防性干预研究、1项诊断方法研究、17项治疗干预研究、1项比较预防与治疗的研究、4项评估 care bundles 的研究。
主要发现
- 24项研究在高收入国家进行,22项在中等偏上或中等偏下收入国家进行,3项在低收入国家进行,7项涉及多个收入水平国家。
- 研究环境、方法和结果差异很大。
- 结果最一致的干预是氨甲环酸用于产后出血治疗和使用 care bundles;在这两种情况下,多项研究预测这些干预要么带来更好的健康结局和成本节约,要么以可接受的成本带来更好的健康结局。
临床怎么用
- 原文未据此给出推荐。
局限性
- 本综述未选择理想环境,因此未进行可转移性评估。
- 部分研究不确定性来源(如效果参数)被探究的程度高于其他不确定性来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postpartum haemorrhage (PPH) is an obstetric emergency. While PPH-related deaths are relatively rare in high-resource settings, PPH continues to be the leading cause of maternal mortality in limited-resource settings. We undertook a systematic review to identify, assess, and synthesise cost-effectiveness evidence on postpartum interventions to prevent, diagnose, or treat PPH. METHODS AND FINDINGS: This systematic review was prospectively registered on PROSPERO (CRD42023438424). We searched Medline, Embase, NHS Economic Evaluation Database (NHS EED), EconLit, CINAHL, Emcare, Web of Science, and Global Index Medicus between 22 June 2023 and 11 July 2024 with no date or language limitations. Full economic evaluations of any postpartum intervention for prevention, detection, or management of PPH were eligible. Study screening, data extraction, and quality assessments (using the CHEC-E tool) were undertaken independently by at least 2 reviewers. We developed narrative syntheses of available evidence for each intervention. From 3,993 citations, 56 studies were included: 33 studies of preventative interventions, 1 study assessed a diagnostic method, 17 studies of treatment interventions, 1 study comparing prevention and treatment, and 4 studies assessed care bundles. Twenty-four studies were conducted in high-income countries, 22 in upper or lower middle-income countries, 3 in low-income countries, and 7 studies involved countries of multiple income levels. Study settings, methods, and findings varied considerably. Interventions with the most consistent findings were the use of tranexamic acid for PPH treatment and using care bundles. In both cases, multiple studies predicted these interventions would either result in better health outcomes and cost savings, or better health outcomes at acceptable costs. Limitations for this review include that no ideal setting was chosen, and therefore, a transferability assessment was not undertaken. In addition, some sources of study uncertainty, such as effectiveness parameters, were interrogated to a greater degree than other sources of uncertainty. CONCLUSIONS: In this systematic review, we extracted, critically appraised, and summarised the cost-effectiveness evidence from 56 studies across 16 different interventions for the prevention, diagnosis, and treatment of PPH. Both the use of tranexamic acid as part of PPH treatment, and the use of comprehensive PPH bundles for prevention, diagnosis, and treatment have supportive cost-effectiveness evidence across a range of settings. More studies utilizing best practice principles are required to make stronger conclusions on which interventions provide the best value. Several high-priority interventions recommended by World Health Organization (WHO) such as administering additional uterotonics, non-pneumatic anti-shock garment, or uterine balloon tamponade (UBT) for PPH management require robust economic evaluations across high-, middle-, and low-resource settings.
引用
- Ginnane JF, Aziz S, Sultana S, et al. The cost-effectiveness of preventing, diagnosing, and treating postpartum haemorrhage: A systematic review of economic evaluations. PLoS Med. 2024. PMID: 39269991. doi:10.1371/journal.pmed.1004461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。